Quick Links

Contact Us

Variation in resting heart rate over 4 years and the risks of myocardial infarction and death among older adults.

Authors: James S Floyd|||Colleen M Sitlani|||Kerri L Wiggins|||Erin Wallace|||Astrid Suchy-Dicey|||Siddique A Abbasi|||Mercedes R Carnethon|||David S Siscovick|||Nona Sotoodehnia|||Susan R Heckbert|||Barbara McKnight|||Kenneth M Rice|||Bruce M Psaty

Journal: Heart (British Cardiac Society)

Publication Type: Journal Article

Date: 2015

DOI: NIHMS641044

ID: 25214500

Affiliations:

Affiliations

    Cardiovascular Health Research Unit, University of Washington, Seattle, Washington, USA Department of Medicine, University of Washington, Seattle, Washington, USA.|||Cardiovascular Health Research Unit, University of Washington, Seattle, Washington, USA Department of Medicine, University of Washington, Seattle, Washington, USA.|||Cardiovascular Health Research Unit, University of Washington, Seattle, Washington, USA Department of Medicine, University of Washington, Seattle, Washington, USA.|||Cardiovascular Health Research Unit, University of Washington, Seattle, Washington, USA.|||Cardiovascular Health Research Unit, University of Washington, Seattle, Washington, USA.|||Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.|||Northwestern University, Chicago, Illinois, USA.|||Cardiovascular Health Research Unit, University of Washington, Seattle, Washington, USA Department of Medicine, University of Washington, Seattle, Washington, USA Department of Epidemiology, University of Washington, Seattle, Washington, USA Group Health Research Institute, Group Health Cooperative, Seattle, Washington, USA.|||Cardiovascular Health Research Unit, University of Washington, Seattle, Washington, USA Department of Medicine, University of Washington, Seattle, Washington, USA.|||Cardiovascular Health Research Unit, University of Washington, Seattle, Washington, USA Department of Epidemiology, University of Washington, Seattle, Washington, USA Group Health Research Institute, Group Health Cooperative, Seattle, Washington, USA.|||Cardiovascular Health Research Unit, University of Washington, Seattle, Washington, USA Department of Biostatistics, University of Washington, Seattle, Washington, USA.|||Cardiovascular Health Research Unit, University of Washington, Seattle, Washington, USA Department of Biostatistics, University of Washington, Seattle, Washington, USA.|||Cardiovascular Health Research Unit, University of Washington, Seattle, Washington, USA Department of Medicine, University of Washington, Seattle, Washington, USA Department of Epidemiology, University of Washington, Seattle, Washington, USA Group Health Research Institute, Group Health Cooperative, Seattle, Washington, USA.

Abstract

Resting heart rate (RHR) is an established predictor of myocardial infarction (MI) and mortality, but the relationship between variation in RHR over a period of several years and health outcomes is unclear. We evaluated the relationship between long-term variation in RHR and the risks of incident MI and mortality among older adults.

Reference List

    Dyer AR, Persky V, Stamler J, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol. 1980;112:736–49.|||Kannel WB, Kannel C, Paffenbarger RS, Jr., et al. Heart rate and cardiovascular mortality: the Framingham Study. American heart journal. 1987;113:1489–94.|||Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. American heart journal. 1991;121:172–7.|||Jouven X, Empana JP, Schwartz PJ, et al. Heart-rate profile during exercise as a predictor of sudden death. The New England journal of medicine. 2005;352:1951–8.|||Benetos A, Thomas F, Bean K, et al. Resting heart rate in older people: a predictor of survival to age 85. Journal of the American Geriatrics Society. 2003;51:284–5.|||Palatini P, Casiglia E, Julius S, et al. High heart rate: a risk factor for cardiovascular death in elderly men. Archives of internal medicine. 1999;159:585–92.|||Diaz A, Bourassa MG, Guertin MC, et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. European heart journal. 2005;26:967–74.|||Fox K, Ford I, Steg PG, et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet. 2008;372:817–21.|||Bohm M, Swedberg K, Komajda M, et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet. 2010;376:886–94.|||Poole-Wilson PA, Uretsky BF, Thygesen K, et al. Mode of death in heart failure: findings from the ATLAS trial. Heart. 2003;89:42–8.|||Nauman J, Janszky I, Vatten LJ, et al. Temporal changes in resting heart rate and deaths from ischemic heart disease. JAMA: the journal of the American Medical Association. 2011;306:2579–87.|||Hutcheon JA, Chiolero A, Hanley JA. Random measurement error and regression dilution bias. BMJ. 2010;340:c2289.|||MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765–74.|||Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895–905.|||Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Annals of epidemiology. 1991;1:263–76.|||Psaty BM, Lee M, Savage PJ, et al. Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. Journal of clinical epidemiology. 1992;45:683–92.|||Psaty BM, Kuller LH, Bild D, et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Annals of epidemiology. 1995;5:270–7.|||Kuller L, Borhani N, Furberg C, et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol. 1994;139:1164–79.|||Ives DG, Fitzpatrick AL, Bild DE, et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Annals of epidemiology. 1995;5:278–85.|||Efron B, Tibshirani R. An Introduction to the Bootstrap. Chapman & Hall/CRC; Boca Raton, FL: 1993.|||R Core Team . R: A language and environment for statistical computing. R Foundation for Statistical Computing V; Austria: 2014. URL http://www.R-project.org/|||Palatini P, Benetos A, Grassi G, et al. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. Journal of hypertension. 2006;24:603–10.|||Greenland S. Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis. Epidemiology. 1995;6:450–4.|||Hartaigh BO, Allore HG, Trentalange M, et al. Elevations in time-varying resting heart rate predict subsequent all-cause mortality in older adults. Eur J Prev Cardiol. 2014|||Jouven X, Empana JP, Escolano S, et al. Relation of heart rate at rest and long-term (>20 years) death rate in initially healthy middle-aged men. The American journal of cardiology. 2009;103:279–83.|||Nicolini P, Ciulla MM, De Asmundis C, et al. The prognostic value of heart rate variability in the elderly, changing the perspective: from sympathovagal balance to chaos theory. Pacing Clin Electrophysiol. 2012;35:622–38.|||Stein PK, Sanghavi D, Sotoodehnia N, et al. Association of Holter-based measures including T-wave alternans with risk of sudden cardiac death in the community-dwelling elderly: the Cardiovascular Health Study. Journal of electrocardiology. 2010;43:251–9.|||Webb AJ, Fischer U, Mehta Z, et al. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010;375:906–15.|||Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010;375:938–48.|||Palatini P, Benetos A, Julius S. Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy. Drugs. 2006;66:133–44.|||Kannel WB, Wilson P, Blair SN. Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. American heart journal. 1985;109:876–85.|||Palatini P, Julius S. Elevated heart rate: a major risk factor for cardiovascular disease. Clinical and experimental hypertension. 2004;26:637–44.|||Palatini P. Heart rate as an independent risk factor for cardiovascular disease: current evidence and basic mechanisms. Drugs. 2007;67(Suppl 2):3–13.|||Lang CC, Gupta S, Kalra P, et al. Elevated heart rate and cardiovascular outcomes in patients with coronary artery disease: clinical evidence and pathophysiological mechanisms. Atherosclerosis. 2010;212:1–8.|||Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA: the journal of the American Medical Association. 2003;289:2534–44.|||Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet. 2005;366:1545–53.|||Fox K, Ford I, Steg PG, et al. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:807–16.|||Persky V, Dyer AR, Leonas J, et al. Heart rate: a risk factor for cancer? Am J Epidemiol. 1981;114:477–87.|||Jouven X, Escolano S, Celermajer D, et al. Heart rate and risk of cancer death in healthy men. PLoS One. 2011;6:e21310.